HCV and HIV Infection among Heroin Addicts in Methadone Maintenance Treatment (MMT) and Not in MMT in Changsha and Wuhan, China

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Wang, Xuyi ^a   Tan, Linxiang ^a   Li, Yi ^b   Zhang, Yao ^b   Zhou, Dongyi ^c   Liu, Tieqiao ^a   Hao, Wei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Mental Health Centre of Wuhan   (China)

^c The Fifth Department of Tuberculosis Diseases   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ATTITUDE TO AIDS; CHINA; CONDOM; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DEPENDENCE TREATMENT; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PREVALENCE; RISK ASSESSMENT; SEROLOGY; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; STRUCTURED QUESTIONNAIRE;

ADULT; CHINA; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; METHADONE; MIDDLE AGED;

HEPATITIS C VIRUS;

EID: 84866658184     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045632     Document Type: Article

References (23)

1. Nelson PK, Mathers BM, Cowie B, Hagan H, Des JD, et al. (2011) Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 378: 571-583 S0140-6736(11)61097-0 [pii];10.1016/S0140-6736(11)61097-0 [doi].
2. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, et al. (2011) A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 31 Suppl 2: 61-80 10.1111/j.1478-3231.2011.02540.x [doi].
3. Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, et al. (2011) Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol 21: 401-416 JST.JSTAGE/jea/JE20100190 [pii].
4. Fletcher NF, McKeating JA, (2012) Hepatitis C virus and the brain. J Viral Hepat 19: 301-306 10.1111/j.1365-2893.2012.01591.x [doi].
5. Lu L, Fang Y, Wang X, (2008) Drug abuse in China: past, present and future. Cell Mol Neurobiol 28: 479-490 10.1007/s10571-007-9225-2 [doi].
6. Tang YL, Hao W, (2007) Improving drug addiction treatment in China. Addiction 102: 1057-1063 ADD1849 [pii];10.1111/j.1360-0443.2007.01849.x [doi].
7. Bao YP, Liu ZM, (2009) Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS 20: 399-405 20/6/399 [pii];10.1258/ijsa.2008.008362 [doi].
8. Yin W, Hao Y, Sun X, Gong X, Li F, et al. (2010) Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol 39 Suppl 2: ii29-ii37 dyq210 [pii];10.1093/ije/dyq210 [doi].
9. Baker A, Kochan N, Dixon J, Wodak A, Heather N, (1995) HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment. Addiction 90: 545-554.
10. Mattick RP, Breen C, Kimber J, Davoli M, (2009) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev CD002209 10.1002/14651858.CD002209.pub2 [doi].
11. Crofts N, Nigro L, Oman K, Stevenson E, Sherman J, (1997) Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction 92: 999-1005.
12. Peles E, Schreiber S, Rados V, Adelson M, (2011) Low risk for hepatitis C seroconversion in methadone maintenance treatment. J Addict Med 5: 214-220 10.1097/ADM.0b013e31820e13dd [doi];01271255-201109000-00008 [pii].
13. Li MQ, Lee SS, Gan ZG, Tan Y, Meng JH, et al. (2007) Achieving a high coverage-the challenge of controlling HIV spread in heroin users. Harm Reduct J 4: 8 1477-7517-4-8 [pii];10.1186/1477-7517-4-8 [doi].
14. Wang X, Zhang T, Ho WZ, (2011) Opioids and HIV/HCV infection. J Neuroimmune Pharmacol 6: 477-489 10.1007/s11481-011-9296-1 [doi].
15. Gyarmathy VA, Neaigus A, Miller M, Friedman SR, Des Jarlais DC, (2002) Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr 30: 448-456.
16. Scheinmann R, Hagan H, Lelutiu-Weinberger C, Stern R, Des Jarlais DC, et al. (2007) Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend 89: 1-12 S0376-8716(06)00434-0 [pii];10.1016/j.drugalcdep.2006.11.014 [doi].
17. Joseph H, Stancliff S, Langrod J, (2000) Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med 67: 347-364.
18. Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, et al. (2007) Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess 11: 1-iv 04/22/01 [pii].
19. Dolan KA, Shearer J, White B, Zhou J, Kaldor J, et al. (2005) Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction 100: 820-828 ADD1050 [pii];10.1111/j.1360-0443.2005.01050.x [doi].
20. Willner-Reid J, Belendiuk KA, Epstein DH, Schmittner J, Preston KL, (2008) Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance. J Subst Abuse Treat 35: 78-86 S0740-5472(07)00246-2 [pii];10.1016/j.jsat.2007.08.011 [doi].
21. Bravo MJ, Vallejo F, Barrio G, Brugal MT, Molist G, et al. (2012) HCV seroconversion among never-injecting heroin users at baseline: No predictors identified other than starting injection. Int J Drug Policy S0955-3959(12)00016-3 [pii];10.1016/j.drugpo.2012.02.002 [doi].
22. Bao YP, Du C, Lu HY, Lian Z, Qiu Y, et al. (2012) The Investigation of HIV and HCV Infection and Risk Factors among Opiate Drug Users in Beijing, China. Am J Drug Alcohol Abuse 38: 140-145 10.3109/00952990.2011.643984 [doi].
23. Hagan H, Des Jarlais DC, Stern R, Lelutiu-Weinberger C, Scheinmann R, et al. (2007) HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. Int J Drug Policy 18: 341-351 S0955-3959(07)00035-7 [pii];10.1016/j.drugpo.2007.01.016 [doi].